Steroids Should Be “Used With Caution” in Primary Immune Thrombocytopenia
Findings showed high-dose, intensive steroid treatment was linked with both short- and long-term adverse events in patients with immune thrombocytopenia.
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 564 results for 'thrombocytopenia'
Sovleplenib Delivers Durable Responses and QOL Improvements in Primary Immune Thrombocytopenia
Sovleplenib may offer QOL improvements for patients with primary immune thrombocytopenia.
Read More
Anti-CD38 monoclonal antibody improves platelet counts in immune thrombocytopenia
1. In this randomized controlled trial, CM313, an anti-CD38 monoclonal antibody therapy, was...
Read More
Bleeding Self-Assessment Often Agrees With Trained Staff in Immune Thrombocytopenia
Researchers tested if self-assessments could support the detection of smaller, but still critical, bleeding incidents in patients with immune thrombocytopenia.
Read MoreTherapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT).
Fcγ-receptors (FcγR) are membrane receptors expressed on a variety of immune cells, specialized in recognition of the Fc part of immunoglobulin G (IgG) antibodies. FcγRIIA-dependent platelet activation in platelet factor 4 (PF4)...
Read MoreAdenosine Deaminase as a Potential Diagnostic and Prognostic Biomarker for Severe Fever with Thrombocytopenia Syndrome.
Severe fever with thrombocytopenia syndrome (SFTS) is a serious infectious disease caused by the Dabie bandavirus, with a high mortality rate. Currently, there are no effective vaccines or specific treatments for SFTS. Early...
Read More
Bleeding Risk: Thrombocytopenia in Atrial Fibrillation & Coronary Disease
The following is a summary of “Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation...
Read More
Efgartigimod Efficacious, Safe for Primary Immune Thrombocytopenia
FRIDAY, Oct. 6, 2023 (HealthDay News) — The first-in-class novel human immunoglobulin G1 Fc...
Read MoreThrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector COVID-19 vaccination in Canada.
Identifying and monitoring adverse events following vaccination contributed to the safety and effectiveness of COVID-19 mass vaccination campaigns. In March 2021, international reports emerged of an adverse event following...
Read MoreAdvertisement
Kinetics and prognostic significance of laboratory markers in patients with severe fever with thrombocytopenia syndrome: insight from a comprehensive analysis.
Severe Fever with Thrombocytopenia Syndrome (SFTS) is an emerging infectious disease with...
Read MoreAnalyzing Eltrombopag in Low-Risk MDS with Thrombocytopenia: Phase II Interim Findings
The following is a summary of “Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS),” published in the...
Read More
Fostamatinib or Thrombopoietic Receptor Agonists for the Treatment of Chronic Immune Thrombocytopenia in Adult Patients: A Real-World Assessment of Safety, Effectiveness and Cost.
Chronic immune thrombocytopenia purpura (ITP) in adults is a serious autoimmune disease in which...
Read More
Examining the Relationship Between Hemorrhage, Thrombocytopenia, and Platelet Transfusion in VA ECMO
The following is a summary of “Interaction of thrombocytopenia, hemorrhage, and platelet...
Read More
Eltrombopag’s Role in CML Patient Care: Managing TKI-induced Thrombocytopenia Safely
The following is a summary of “Efficacy and safety of eltrombopag in treating TKI-induced...
Read MorePlatelet Transfusion Prior CVC Placement in Thrombocytopenia Patients
The following is a summary of the article “Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia,” published in the May 2023 issue of Hematology by Baarle et al. Due to evidence gaps, there are...
Read MoreThrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
Thrombosis with thrombocytopenia syndrome (TTS) is a very rare disorder described after vaccination with adenoviral vector-based COVID-19 vaccines. Co-occurring thrombosis with thrombocytopenia reported after vaccination can be...
Read MoreIPS Aids in Understanding Thrombocytopenia Mechanisms in MDS and CMML
The following is a summary of “Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia,” published...
Read More
CD8+ T-Cell Clones and Their Impact on Immune Thrombocytopenia
The following is a summary of “The role of CD8+ T-cell clones in immune...
Read MoreRetrospective Analysis: Thrombocytopenia in Septic Shock
The following is a summary of “Clinical significance of thrombocytopenia in patients with septic shock: An observational retrospective study,” published in the March 2023 issue of the Critical Care by Péju et al. It...
Read More
Assessing In-Hospital Mortality of Heparin-Induced Thrombocytopenia in Patients With ESKD
The following is a summary of “In-hospital mortality of heparin-induced thrombocytopenia in...
Read More